Camera-based FDG PET and67Ga SPECT in Evaluation of Lymphoma: Comparative Study
- 1 May 2003
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 227 (2) , 353-360
- https://doi.org/10.1148/radiol.2272020195
Abstract
PURPOSE: To compare gallium 67 (67Ga) scintigraphy and camera-based fluorodeoxyglucose (FDG) positron emission tomography (PET) in the evaluation of patients with lymphoma. MATERIALS AND METHODS: The performance of 67Ga scintigraphy and camera-based FDG PET in the detection of lymphoma was retrospectively evaluated and compared in 84 patients with lymphoma, with 219 suspected sites of disease. Eighty-nine percent of patients were examined during or after treatment. Camera-based FDG PET was initiated by equivocal characterization of the status of disease based on clinical, radiologic, and 67Ga scintigraphic assessment. Findings of 67Ga scintigraphy and camera-based FDG PET were compared on a per-patient and per-site basis for the whole group, for histologic subtypes, and for anatomic locations. Comparison of sensitivity, specificity, and accuracy between the two modalities for detection of lymphoma was performed with the McNemar test. RESULTS: There was a statistically significant difference in sensitivity, specificity, and accuracy of 67Ga scintigraphy and camera-based FDG PET at both patient- and site-based analysis. 67Ga scintigraphy helped to accurately define disease state in 63% of patients and in 33% of sites, compared with 83% and 87%, respectively, for camera-based FDG PET. For discordant findings between the two modalities, camera-based FDG PET findings were confirmed as true-positive in 71% and as true-negative in 92% of patients. Camera-based FDG PET had a significantly higher detection rate for both nodal and extranodal lymphoma sites. It provided accurate assessment of lymphoma involvement of the skeleton in 93% of sites compared with 29% for 67Ga scintigraphy and excluded active lymphoma in 10 67Ga-positive benign parahilar sites. CONCLUSION: In this selected group of patients with lymphoma, camera-based FDG PET allowed a significantly more accurate definition of active disease compared with that allowed with 67Ga scintigraphy. © RSNA, 2003Keywords
This publication has 29 references indexed in Scilit:
- Imaging of Malignant Lymphomas with F-18 FDG Coincidence Detection Positron Emission TomographyClinical Nuclear Medicine, 2000
- 25. Positron Emission Tomography in Hodgkin's Disease Correlation with Computed Tomography and Gallium 67 Citrate ImagingClinical Positron Imaging, 2000
- PET imaging in oncologySeminars in Nuclear Medicine, 2000
- Aggressive Non-Hodgkin Lymphoma: Early Prediction of Outcome with67Ga ScintigraphyRadiology, 2000
- Comparison of FDG PET and positron coincidence detection imaging using a dual-head gamma camera with 5/8-inch NaI(Tl) crystals in patients with suspected body malignanciesEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Hodgkin Disease: Prediction of Outcome with67Ga Scintigraphy after One Cycle of ChemotherapyRadiology, 1999
- Positron Emission Tomography with 18-Fluorodeoxyglucose in the Staging and Follow-up of Lymphoma in the ChestActa Oncologica, 1999
- The continuing clinical role of gallium 67 scintigraphy in the age of receptor imagingSeminars in Nuclear Medicine, 1997
- Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: Potential for error in interpretationSeminars in Nuclear Medicine, 1996
- Magnetic boundary conditions for pinch dischargesNuclear Fusion, 1981